IP Library Granted Patent US 7,157,412
Granted Patent B2
US 7,157,412 · App. 10/820,354 · Granted Jan 2, 2007

Alkylamine as an antimicrobial agent in ophthalmic compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,412
App. No.
10/820,354
Granted
Jan 2, 2007
Kind
B2
Abstract

A multi-purpose contact lens care solution having high activity against fungi and certain bacteria comprising, in liquid aqueous medium, an alkylamine having the following formula, where R1 is a C 13-17 alkyl, and R2 and R3 are each independently H or —CH 3 , and a non-ionic surfactant. The solution may optionally also include additional antimicrobial components, a buffer component, a viscosity inducing component, a surfactant, taurine, propylene glycol and/or a tonicity component. This solution additionally prevents losses in ocular tissue membrane integrity during contact lens wear.

Claims (42)

1. A multi-purpose solution for contact lenses comprising:

an aqueous liquid medium;

from about 0.1 ppm to about 10 ppm of an alkylamine

where R1 is a C 13-17 alkyl and R2 and R3 are each independtly H or CH 3 ;

the alkylamine comprises a C 13-17 alkyl; and

a non-ionic surfactant that is present in the solution in an amount effective to (a) render the alkylamine soluble in the aqueous solution without neutralizing the alkylamine antimicrobial activity effect and (b) to clean a contact lens contacted with said solution.

2. The solution as in claim 1 , wherein the alkylamine is selected from the group consisting of myristylamine and cetylamine.

3. The solution as in claim 1 , wherein the non-ionic surfactant is a polyoxypropylenepolyoxyethylene co-block polymer.

4. The solution as in claim 1 , further comprising a second antimicrobial component.

5. The solution as in claim 1 , further comprising a viscosity inducing component selected from the group consisting of cellulosic derivatives and mixtures thereof in the range of about 0.05% to about 5.0% (w/v) of the total solution.

6. The solution as in claim 1 , further comprising a chelating component in an amount of less than 0.05% (w/v) of the total solution.

7. The solution as in claim 1 , further comprising a tonicity component in an amount effective in providing the desired tonicity to the solution.

8. The solution as in claim 1 , further comprising a buffer component in an amount effective in maintaining the pH of said solution within a physiologically acceptable range.

9. A multi-purpose solution for contact lens care comprising:

an aqueous liquid medium;

from about 0.1 ppm to about 10 ppm of a first antimicrobial component in an amount effective to disinfect a contact lens contacted with said solution, the antimicrobial component comprising an alkylamine

where R1 is a C 13-17 alkyl and R2 and R3 are each independtly H or CH 3 ;

a non-ionic surfactant that is present in the solution in an amount effective to (a) render the alkylamine soluble in the aqueous solution without neutralizing the alkylamine antimicrobial activity and (b) to clean the contact lens contacted with said solution;

a buffer component in an amount effective in maintaining the pH of said solution within a physiologically acceptable range;

a viscosity inducing component selected from the group consisting of cellulosic derivatives and mixtures thereof in the range of about 0.05% to about 5.0% (w/v) of the total solution;

a chelating component in an amount of less than 0.05% (w/v) of the total solution; and

a tonicity component in an amount effective in providing the desired tonicity to said solution.

10. The solution as in claim 9 , wherein the alkylamine is selected from the group consisting of myristylamine and cetylamine.

11. The solution as in claim 9 , wherein the non-ionic surfactant is a polyoxypropylenepolyoxyethylene co-block polymer.

12. The multi-purpose solution of claim 9 , further comprising a second antimicrobial component.

13. The multi-purpose solution of claim 12 , wherein the antimicrobial component is selected from the group consisting of biguanides, biguanide polymers, monomeric quaternary ammonium compound, salts thereof and mixtures thereof.

14. The multi-purpose solution of claim 12 , wherein the second antimicrobial component is present in an amount ranging from about 0.1 ppm to about 3 ppm.

15. The multi-purpose solution of claim 9 , wherein the non-ionic surfactant is selected from the group consisting of poly (oxyethylene)-poly(oxypropylene) block copolymers and mixtures thereof, and is present in an amount in a range of about 0.01% to about 1.0% (w/v).

16. The multi-purpose solution of claim 9 , wherein the non-ionic surfactant is present in an amount in the range of about 0.01% to about 1.0% (w/v).

17. The multi-purpose solution of claim 9 , wherein the buffer component includes boric acid.

18. The multi-purpose solution of claim 9 , wherein the buffer component is present in an amount in a range of about 0.01% to about 1% (w/v).

19. The multi-purpose solution of claim 9 , wherein the viscosity inducing component is hydroxypropylmethyl cellulose.

20. The multi-purpose solution of claim 9 , wherein the tonicity component includes a combination of sodium chloride and potassium chloride and is present in a range of about 0.4% to about 1.5% (w/v).

21. The multi-purpose solution of claim 9 , wherein the chelating component is EDTA.

22. The multi-purpose solution of claim 9 , further comprising taurine.

23. A multi-purpose solution for contact lenses comprising:

an aqueous liquid medium;

from about 0.1 ppm to about 10 ppm of a first antimicrobial agent comprising an alkylamine

where R1 is a C 13-17 alkyl and R2 and R3 are each independtly H or CH 3 ;

a second antimicrobial agent;

a non-ionic surfactant that is present in the solution in an amount effective to render the alkylamine soluble in the aqueous solution without neutralizing the alkylamine antimicrobial activity; and

taurine in an amount effective to protect ocular tissue cell membranes.

Assignments (7)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047150/0976 →
MERGER Recorded Jul 29, 2009
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 023234/0277 →
RELEASE OF SECURITY INTEREST Recorded Feb 27, 2009
From: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 022320/0427 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 29, 2007
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019501/0069 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 16386/0001 Recorded Apr 4, 2007
From: BANK OF AMERICA, N.A.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 019116/0124 →
SECURITY AGREEMENT Recorded Jul 29, 2004
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 016386/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2004
From: YU, ZHI-JIAN
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 015194/0451 →